NICE draft guidance recommends sapropterin for children with rare inherited metabolic condition phenylketonuria

NICE has today (25 February 2021) issued draft guidance for public consultation which recommends sapropterin (also called Kuvan and made by BioMarin) for treating phenylketonuria (PKU) in children aged up to 18.

Read news story

Blogs

NICE Talks podcasts

NICE Talks brings you the real-life experiences of people working within the NHS, public health and social care.

You will hear the stories behind our work to improve care across the country through evidence-based guidance.

Press and media

Contact the press office: 0300 323 0142 | pressoffice@nice.org.uk